Approaches for prevention of antibacterial drug resistance

Kaur, A; Sharma, RB; Dua, K

Approaches for prevention of antibacterial drug resistance

Kaur, A Sharma, RB Dua, K

Permalink

Publisher:: IGI Global
Publication Type:: Chapter
Citation:: Contemporary Approaches to Mitigating Antibacterial Drug Resistance, 2024, pp. 51-91
Issue Date:: 2024-04-01

Recently Added

	Filename	Description	Size
	pdf.aspx.pdf	Published version	958.98 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is new to OPUS and is not currently available.

Full metadata record

Field	Value	Language
dc.contributor.author	Kaur, A
dc.contributor.author	Sharma, RB
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2024-07-19T03:01:30Z
dc.date.available	2024-07-19T03:01:30Z
dc.date.issued	2024-04-01
dc.identifier.citation	Contemporary Approaches to Mitigating Antibacterial Drug Resistance, 2024, pp. 51-91
dc.identifier.isbn	9798369315408
dc.identifier.uri	http://hdl.handle.net/10453/179796
dc.description.abstract	Antibiotic resistance, the phenomenon where bacteria evolve to withstand the effects of antibiotics, has become a pressing global health crisis. Over the past century, antibiotics have revolutionized medicine, saved countless lives, and enabled medical advancements. However, the overuse and misuse of these life-saving drugs, in human medicine, agriculture, and animal husbandry, have contributed to the development of antibiotic-resistant bacteria. This resistance not only threatens our ability to treat common infections but also compromises modern medical procedures such as surgeries, chemotherapy, and organ transplants. The consequences of antibiotic resistance are dire. Infections once easily treatable can become deadly, and the economic burden on healthcare systems is substantial. The pipeline for new antibiotics is alarmingly dry, with pharmaceutical companies finding it financially unattractive to invest in these short-course drugs. This scarcity of novel antibiotics further exacerbates the problem. Addressing antibiotic resistance requires a multifaceted approach, including responsible antibiotic use, the development of new antibiotics, and improved infection prevention and control measures. Global cooperation and comprehensive policies are crucial in combating this issue, recognizing its crossborder nature. The public's understanding of antibiotic resistance is key to its mitigation. Public awareness campaigns and education are pivotal in promoting responsible antibiotic use and infection prevention. By collectively tackling antibiotic resistance, we can ensure the continued effectiveness of antibiotics and safeguard the health of current and future generations.
dc.language	en
dc.publisher	IGI Global
dc.relation.ispartof	Contemporary Approaches to Mitigating Antibacterial Drug Resistance
dc.relation.ispartofseries	Advances in Medical Technologies and Clinical Practice
dc.relation.isbasedon	10.4018/979-8-3693-1540-8.ch003
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.title	Approaches for prevention of antibacterial drug resistance
dc.type	Chapter
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	recently_added	*
dc.date.updated	2024-07-19T03:01:28Z
pubs.publication-status	Published

Abstract:

Antibiotic resistance, the phenomenon where bacteria evolve to withstand the effects of antibiotics, has become a pressing global health crisis. Over the past century, antibiotics have revolutionized medicine, saved countless lives, and enabled medical advancements. However, the overuse and misuse of these life-saving drugs, in human medicine, agriculture, and animal husbandry, have contributed to the development of antibiotic-resistant bacteria. This resistance not only threatens our ability to treat common infections but also compromises modern medical procedures such as surgeries, chemotherapy, and organ transplants. The consequences of antibiotic resistance are dire. Infections once easily treatable can become deadly, and the economic burden on healthcare systems is substantial. The pipeline for new antibiotics is alarmingly dry, with pharmaceutical companies finding it financially unattractive to invest in these short-course drugs. This scarcity of novel antibiotics further exacerbates the problem. Addressing antibiotic resistance requires a multifaceted approach, including responsible antibiotic use, the development of new antibiotics, and improved infection prevention and control measures. Global cooperation and comprehensive policies are crucial in combating this issue, recognizing its crossborder nature. The public's understanding of antibiotic resistance is key to its mitigation. Public awareness campaigns and education are pivotal in promoting responsible antibiotic use and infection prevention. By collectively tackling antibiotic resistance, we can ensure the continued effectiveness of antibiotics and safeguard the health of current and future generations.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/179796